Business Wire

Massive Bio Announces First Patient Enrolled in Its Pivotal Global SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NEW YORK--(BUSINESS WIRE)--Massive Bio, Inc., a leader in providing simplified and affordable access to precision oncology to cancer patients treated at community-based oncology practices, announced ...
Business Wire

Massive Bio Launches the Movement to Match 100,000 Cancer Patients to Clinical Trials: 100K SINGULARITY PROGRAM

This ambitious program leverages Massive Bio’s AI capabilities and Trial Command Center to significantly accelerate oncology clinical research and bring clinical trial access to the masses NEW ...
Morningstar

Massive Bio Publishes Landmark Prospective Study Demonstrating AI-Driven Clinical Trial Matching at Scale in 3,804 Cancer Patients

Neuro-symbolic, multi-agent AI system achieves 4x faster trial matching with oncologist-confirmed accuracy across 17,000+ matches, published in ESMO Real World Data and Digital Oncology special issue ...